Intestinal probiotic fungi improve PCOS by sensing metformin signaling and inhibiting gut derived ceramide levels
Abstract
Abstract Polycystic ovary syndrome (PCOS) is the leading cause of anovulatory infertility. Although metformin improves metabolic dysfunction in PCOS, its therapeutic potential in non-insulin-resistant patients and the role in mediating gut fungi remain unexplored. We followed up with PCOS patients who received metformin for clinical treatment, and the results showed that metformin significantly improved reproductive function in non-insulin resistant PCOS patients. We identified Alternaria alternata (A. alternata) as a metformin-enriched gut fungus that alleviates PCOS in mice by suppressing the intestinal SMPD3, thereby reducing ceramide levels and endoplasmic reticulum stress in granulosa cells to improve ovarian function. Notably, we validated γ-tocotrienol as the key A. alternata metabolite mediating these therapeutic effects, and conformed its upregulation post-metformin treatment in PCOS patients, correlating with improved clinical characteristics. Our findings reveal that metformin improves PCOS by modulating gut fungi and inhibiting ceramide synthesis, offering a promising therapeutic strategy for non-insulin-resistant PCOS.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.